Related by context. Frequent words. (Click for all words.) 64 SBIR Phase 57 By Arek Sarkissian 56 Phase IIB 56 QTDP 54 multicenter Phase 53 SBIR grant 52 Commences Phase 52 SBIR Grant 51 NASDAQ OSIR 51 Chiral Quest 51 Therapeutic Discovery Project 51 Initiate Phase 51 Qualifying Therapeutic Discovery 50 Nanotherapeutics 50 Committed Equity 50 Stock Repurchase Plan 50 GRNVAC1 50 BioMarin Genzyme LLC 50 Phases II 49 SBIR grants 49 WILEX 49 placebo controlled Phase 49 Corautus 49 JAK1 49 Translational Science Award 49 Liquidia Technologies 49 Investigational Device Exemption 49 Bruker Optics 49 BioDiscovery 48 preclinical toxicology 48 EvoGenix 48 Guanilib 48 Br J Psychiatry 48 Diatos 48 Canada SDTC 48 Cellzome 48 Tesetaxel 48 Revance 47 Æterna Zentaris 47 BioCheck 47 Phase IIa clinical trials 47 NanoBio Corporation 47 Argatroban 47 KNS # 47 Initiates Phase II 47 BioDelivery Sciences 47 Flow Through LP 47 BioCancell 47 ATTAIN 47 NYSTAR 47 BioSystems 47 NASDAQ BPAX 47 Incentive Compensation Plan 47 Fibrillex TM 46 Orphan Drug designation 46 Osteocel 46 NASDAQ DYAX 46 Investigational Device Exemption IDE 46 Private Placement Offering 46 ARCA biopharma Inc. 46 Incumbent Worker 46 Mikros Systems Corporation 46 Arteriocyte 46 Althea Technologies 46 Omeros Corporation 46 Inc. NYSE OHI 46 liposomal formulation 46 convertible debenture financing 46 methylnaltrexone 46 Phase 46 Task Orders 46 glufosfamide 46 GSK# [001] 46 Elixir Pharmaceuticals 46 Repligen Corporation 46 Inovio Pharmaceuticals 46 Warburg Pincus Private Equity 46 Ciphergen Biosystems Inc. 46 registrational trial 46 Highstar 46 JDIG 46 AusIndustry 46 ASA# 46 Traficet EN 46 AHP grant 46 metastatic hormone refractory 45 PRECiSE 45 neurogenic orthostatic hypotension 45 IND Investigational New 45 Biolex Therapeutics 45 SBIR STTR 45 Lpath 45 Initiates Phase 45 Innovation CFI 45 GoldTrain 45 Nasdaq Hearings Panel 45 Omigard 45 Daclizumab 45 orphan designation 45 Chemokine 45 Integral Technologies